Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	66
Overall Study	STARTED	Ziltivekimab 7.5 mg	66
Overall Study	STARTED	Ziltivekimab 15 mg	66
Overall Study	STARTED	Ziltivekimab 30 mg	66
Overall Study	Intent-to-treat Analysis Population	Placebo	66
Overall Study	Intent-to-treat Analysis Population	Ziltivekimab 7.5 mg	66
Overall Study	Intent-to-treat Analysis Population	Ziltivekimab 15 mg	66
Overall Study	Intent-to-treat Analysis Population	Ziltivekimab 30 mg	66
Overall Study	Safety Analysis Population	Placebo	65
Overall Study	Safety Analysis Population	Ziltivekimab 7.5 mg	65
Overall Study	Safety Analysis Population	Ziltivekimab 15 mg	66
Overall Study	Safety Analysis Population	Ziltivekimab 30 mg	65
Overall Study	Treated	Placebo	65
Overall Study	Treated	Ziltivekimab 7.5 mg	65
Overall Study	Treated	Ziltivekimab 15 mg	66
Overall Study	Treated	Ziltivekimab 30 mg	65
Overall Study	COMPLETED	Placebo	60
Overall Study	COMPLETED	Ziltivekimab 7.5 mg	57
Overall Study	COMPLETED	Ziltivekimab 15 mg	60
Overall Study	COMPLETED	Ziltivekimab 30 mg	59

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03926117/flow